Corden Pharma GmbH

Formed as the global pharmaceutical service & manufacturing platform of International Chemical Investors Group in 2006, CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Excipients, Drug Products, and associated Packaging Services. Through a growing network of cGMP facilities across Europe and the US organized under five Technology Platforms – Peptides - Lipids & Carbohydrates - Highly Potent & Oncology - Injectables - Small Molecules – CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products.

 Full-Service CDMO Organized under 5 Technology Platforms

 11 cGMP Manufacturing Facilities in Europe / US and 1 R&D Research Laboratory

 2600 Employees

OUR VISION

CordenPharma’s vision is to be a trusted, reliable and highly respected CDMO to Pharmaceutical & Biotechnology companies by providing industry-leading Integrated Product Solutions with integrity, transparency & flexibility on all levels of the organization.

OUR MISSION

We strive for excellence in supporting global Pharmaceutical & Biotechnology customers with high quality products for the well-being of patients.